N4-acetylcytidine modification bridges metabolic reprogramming and immune evasion in cancer: mechanisms and therapeutic implications - Top-Institutions - MDSpire

N4-acetylcytidine modification bridges metabolic reprogramming and immune evasion in cancer: mechanisms and therapeutic implications

  • By

  • Ming-Zhu Jin

  • Wen Di

  • June 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    National Cancer Institute, Center for Cancer Research
    National Cancer Institute, Center for Cancer Research

    Bethesda, Maryland

    Key Differentiators

    • Oncology
    • Cancer Research

  • #2

    Abramson Cancer Center
    Abramson Cancer Center

    Philadelphia, Pennsylvania

    Key Differentiators

    • Oncology
    • Comprehensive Cancer Care

Original Source(s)

N4-acetylcytidine modification bridges metabolic reprogramming and immune evasion in cancer: mechanisms and therapeutic implications

  • by Ming-Zhu Jin, Wen Di

  • June 29, 2026

Related Content

Joseph Fraumeni Jr., pioneering cancer genetics researcher, devoted his life to families like mine

ESMO Breast Cancer 2026 Highlights Panel Discussion

Harold Burstein, MD, PhD; Sara Tolaney, MD, MPH; Erica L. Mayer, MD, MPH; Nancy Lin, MD; and Ana C. Garrido-Castro, MD discuss important breast cancer research presented at the 2026 ESMO Breast Cancer Congress.

  • June 26, 2026

  • 1 min
Endoscopic and histopathological phenotypes of early gastric neoplasia: toward an integrative host-response framework